{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28701733", "DateCompleted": {"Year": "2017", "Month": "11", "Day": "21"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "07", "Day": "12"}], "Language": ["eng"], "ELocationID": ["69", "10.1038/s41467-017-00057-x"], "Journal": {"ISSN": "2041-1723", "JournalIssue": {"Volume": "8", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Jul", "Day": "12"}}, "Title": "Nature communications", "ISOAbbreviation": "Nat Commun"}, "ArticleTitle": "Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy.", "Pagination": {"StartPage": "69", "MedlinePgn": "69"}, "Abstract": {"AbstractText": ["The imminent threat of viral epidemics and pandemics dictates a need for therapeutic approaches that target viral pathology irrespective of the infecting strain. Reactive oxygen species are ancient processes that protect plants, fungi and animals against invading pathogens including bacteria. However, in mammals reactive oxygen species production paradoxically promotes virus pathogenicity by mechanisms not yet defined. Here we identify that the primary enzymatic source of reactive oxygen species, NOX2 oxidase, is activated by single stranded RNA and DNA viruses in endocytic compartments resulting in endosomal hydrogen peroxide generation, which suppresses antiviral and humoral signaling networks via modification of a unique, highly conserved cysteine residue (Cys98) on Toll-like receptor-7. Accordingly, targeted inhibition of endosomal reactive oxygen species production abrogates influenza A virus pathogenicity. We conclude that endosomal reactive oxygen species promote fundamental molecular mechanisms of viral pathogenicity, and the specific targeting of this pathogenic process with endosomal-targeted reactive oxygen species inhibitors has implications for the treatment of viral disease.Production of reactive oxygen species is an ancient antimicrobial mechanism, but its role in antiviral defense in mammals is unclear. Here, To et al. show that virus infection activates endosomal NOX2 oxidase and restricts TLR7 signaling, and that an endosomal NOX2 inhibitor decreases viral pathogenicity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Program in Chronic Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, College of Science, Engineering & Health, RMIT University, Bundoora, Victoria, 3083, Australia."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, 3800, Australia."}], "LastName": "To", "ForeName": "Eunice E", "Initials": "EE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Program in Chronic Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, College of Science, Engineering & Health, RMIT University, Bundoora, Victoria, 3083, Australia."}], "LastName": "Vlahos", "ForeName": "Ross", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, 3800, Australia."}], "LastName": "Luong", "ForeName": "Raymond", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia."}], "LastName": "Halls", "ForeName": "Michelle L", "Initials": "ML"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, 3000, Australia."}], "LastName": "Reading", "ForeName": "Patrick C", "Initials": "PC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Monash Lung and Sleep, Department of Medicine, Monash Medical Centre, Monash University, Clayton, Victoria, 3168, Australia."}], "LastName": "King", "ForeName": "Paul T", "Initials": "PT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, 3800, Australia."}, {"Identifier": [], "Affiliation": "Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, 185 Cambridge Street, Boston, Massachusetts, 02114, USA."}], "LastName": "Chan", "ForeName": "Christopher", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Anatomy & Microbiology, School of Life Sciences, La Trobe University, Melbourne, Victoria, 3086, Australia."}], "LastName": "Drummond", "ForeName": "Grant R", "Initials": "GR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Anatomy & Microbiology, School of Life Sciences, La Trobe University, Melbourne, Victoria, 3086, Australia."}], "LastName": "Sobey", "ForeName": "Christopher G", "Initials": "CG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, 3800, Australia."}], "LastName": "Broughton", "ForeName": "Brad R S", "Initials": "BRS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Priority Research Centre's Grow Up Well and Healthy Lungs, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, The University of Newcastle, and Hunter Medical Research Institute, New South Wales, 2305, Australia."}], "LastName": "Starkey", "ForeName": "Malcolm R", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, 3000, Australia."}], "LastName": "van der Sluis", "ForeName": "Renee", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, 3000, Australia."}, {"Identifier": [], "Affiliation": "Department of Infectious Diseases, Alfred Hospital and Monash University, Melbourne, 3004, Australia."}], "LastName": "Lewin", "ForeName": "Sharon R", "Initials": "SR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Program in Chronic Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, College of Science, Engineering & Health, RMIT University, Bundoora, Victoria, 3083, Australia."}], "LastName": "Bozinovski", "ForeName": "Steven", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2,, Ireland."}], "LastName": "O'Neill", "ForeName": "Luke A J", "Initials": "LAJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia."}, {"Identifier": [], "Affiliation": "Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia."}, {"Identifier": [], "Affiliation": "Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia."}], "LastName": "Quach", "ForeName": "Tim", "Initials": "T"}, {"Identifier": ["0000-0003-3474-7551"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia."}, {"Identifier": [], "Affiliation": "Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia."}], "LastName": "Porter", "ForeName": "Christopher J H", "Initials": "CJH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Pharmacy and Medical Sciences, Sansom Institute for Health Research, Division of Health Sciences, University of South Australia, Adelaide, 5001, Australia."}], "LastName": "Brooks", "ForeName": "Doug A", "Initials": "DA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Discipline of Histopathology, School of Medicine, Trinity Translational Medicine Institute (TTMI), Trinity College Dublin, Ireland."}, {"Identifier": [], "Affiliation": "Sir Patrick Dun's Laboratory, Central Pathology Laboratory, St James's Hospital, Dublin 8, Ireland."}, {"Identifier": [], "Affiliation": "Molecular Pathology Laboratory, The Coombe Women and Infants University Hospital, Dublin 8, Ireland."}], "LastName": "O'Leary", "ForeName": "John J", "Initials": "JJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Program in Chronic Infectious and Inflammatory Diseases, School of Health and Biomedical Sciences, College of Science, Engineering & Health, RMIT University, Bundoora, Victoria, 3083, Australia. Stavros.selemidis@RMIT.edu.au."}, {"Identifier": [], "Affiliation": "Department of Pharmacology, Infection and Immunity Program, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, 3800, Australia. Stavros.selemidis@RMIT.edu.au."}], "LastName": "Selemidis", "ForeName": "Stavros", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Nat Commun", "NlmUniqueID": "101528555", "ISSNLinking": "2041-1723"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Glycoproteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Tlr7 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Toll-Like Receptor 7"}, {"RegistryNumber": "EC 1.6.3.-", "NameOfSubstance": "Cybb protein, mouse"}, {"RegistryNumber": "EC 1.6.3.-", "NameOfSubstance": "NADPH Oxidase 2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Disease Progression"}, {"QualifierName": ["metabolism"], "DescriptorName": "Endosomes"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["drug effects", "pathogenicity"], "DescriptorName": "Influenza A virus"}, {"QualifierName": ["metabolism"], "DescriptorName": "Membrane Glycoproteins"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": ["antagonists & inhibitors", "genetics", "metabolism"], "DescriptorName": "NADPH Oxidase 2"}, {"QualifierName": ["drug therapy", "metabolism", "virology"], "DescriptorName": "Orthomyxoviridae Infections"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "Toll-Like Receptor 7"}, {"QualifierName": [], "DescriptorName": "Virulence"}], "CoiStatement": "The authors declare no competing financial interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Kawahara T, Quinn MT, Lambeth JD. Molecular evolution of the reactive oxygen-generating NADPH oxidase (Nox/Duox) family of enzymes. BMC Evol. Biol. 2007;7:109. doi: 10.1186/1471-2148-7-109.", "ArticleIdList": ["10.1186/1471-2148-7-109", "PMC1940245", "17612411"]}, {"Citation": "Aguirre J, Lambeth JD. Nox enzymes from fungus to fly to fish and what they tell us about Nox function in mammals. Free Radic. Biol. Med. 2010;49:1342\u20131353. doi: 10.1016/j.freeradbiomed.2010.07.027.", "ArticleIdList": ["10.1016/j.freeradbiomed.2010.07.027", "PMC2981133", "20696238"]}, {"Citation": "Imai Y, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133:235\u2013249. doi: 10.1016/j.cell.2008.02.043.", "ArticleIdList": ["10.1016/j.cell.2008.02.043", "PMC7112336", "18423196"]}, {"Citation": "Snelgrove RJ, Edwards L, Rae AJ, Hussell T. An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur. J. Immunol. 2006;36:1364\u20131373. doi: 10.1002/eji.200635977.", "ArticleIdList": ["10.1002/eji.200635977", "16703568"]}, {"Citation": "To EE, Broughton BR, Hendricks KS, Vlahos R, Selemidis S. Influenza A virus and TLR7 activation potentiate NOX2 oxidase-dependent ROS production in macrophages. Free Radic. Res. 2014;48:940\u2013947. doi: 10.3109/10715762.2014.927579.", "ArticleIdList": ["10.3109/10715762.2014.927579", "24869957"]}, {"Citation": "Vlahos R, et al. Inhibition of Nox2 oxidase activity ameliorates influenza A virus-induced lung inflammation. PLoS Pathog. 2011;7:e1001271. doi: 10.1371/journal.ppat.1001271.", "ArticleIdList": ["10.1371/journal.ppat.1001271", "PMC3033375", "21304882"]}, {"Citation": "Vlahos R, Stambas J, Selemidis S. Suppressing production of reactive oxygen species (ROS) for influenza A virus therapy. Trends Pharmacol. Sci. 2012;33:3\u20138. doi: 10.1016/j.tips.2011.09.001.", "ArticleIdList": ["10.1016/j.tips.2011.09.001", "21962460"]}, {"Citation": "Vlahos R, Selemidis S. NADPH oxidases as novel pharmacologic targets against influenza A virus infection. Mol. Pharmacol. 2014;86:747\u2013759. doi: 10.1124/mol.114.095216.", "ArticleIdList": ["10.1124/mol.114.095216", "25301784"]}, {"Citation": "Selemidis S, Sobey CG, Wingler K, Schmidt HH, Drummond GR. NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition. Pharmacol. Ther. 2008;120:254\u2013291. doi: 10.1016/j.pharmthera.2008.08.005.", "ArticleIdList": ["10.1016/j.pharmthera.2008.08.005", "18804121"]}, {"Citation": "Drummond GR, Selemidis S, Griendling KK, Sobey CG. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 2011;10:453\u2013471. doi: 10.1038/nrd3403.", "ArticleIdList": ["10.1038/nrd3403", "PMC3361719", "21629295"]}, {"Citation": "Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 2007;87:245\u2013313. doi: 10.1152/physrev.00044.2005.", "ArticleIdList": ["10.1152/physrev.00044.2005", "17237347"]}, {"Citation": "Cossart P, Helenius A. Helenius A. Endocytosis of viruses and bacteria. Cold Spring Harbor Perspect. Biol. 2014;6:a016972. doi: 10.1101/cshperspect.a016972.", "ArticleIdList": ["10.1101/cshperspect.a016972", "PMC4107984", "25085912"]}, {"Citation": "Iwasaki A, Pillai PS. Innate immunity to influenza virus infection. Nat. Rev. Immunol. 2014;14:315\u2013328. doi: 10.1038/nri3665.", "ArticleIdList": ["10.1038/nri3665", "PMC4104278", "24762827"]}, {"Citation": "Campbell AM, Kashgarian M, Shlomchik MJ. NADPH oxidase inhibits the pathogenesis of systemic lupus erythematosus. Sci. Transl. Med. 2012;4:157ra141. doi: 10.1126/scitranslmed.3004801.", "ArticleIdList": ["10.1126/scitranslmed.3004801", "PMC3704198", "23100627"]}, {"Citation": "Kelkka T, et al. Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature. Antioxid. Redox Signal. 2014;21:2231\u20132245. doi: 10.1089/ars.2013.5828.", "ArticleIdList": ["10.1089/ars.2013.5828", "PMC4224049", "24787605"]}, {"Citation": "Li Q, et al. Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol. Cell. Biol. 2006;26:140\u2013154. doi: 10.1128/MCB.26.1.140-154.2006.", "ArticleIdList": ["10.1128/MCB.26.1.140-154.2006", "PMC1317618", "16354686"]}, {"Citation": "Chu Y, et al. Endocytosis of extracellular superoxide dismutase into endothelial cells: role of the heparin-binding domain. Arterioscler. Thromb. Vasc. Biol. 2006;26:1985\u20131990. doi: 10.1161/01.ATV.0000234921.88489.5c.", "ArticleIdList": ["10.1161/01.ATV.0000234921.88489.5c", "16809550"]}, {"Citation": "Lund JM, et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl Acad. Sci. USA. 2004;101:5598\u20135603. doi: 10.1073/pnas.0400937101.", "ArticleIdList": ["10.1073/pnas.0400937101", "PMC397437", "15034168"]}, {"Citation": "Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004;303:1529\u20131531. doi: 10.1126/science.1093616.", "ArticleIdList": ["10.1126/science.1093616", "14976261"]}, {"Citation": "Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 2009;206:79\u201387. doi: 10.1084/jem.20081667.", "ArticleIdList": ["10.1084/jem.20081667", "PMC2626661", "19139171"]}, {"Citation": "Allen IC, et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 2009;30:556\u2013565. doi: 10.1016/j.immuni.2009.02.005.", "ArticleIdList": ["10.1016/j.immuni.2009.02.005", "PMC2803103", "19362020"]}, {"Citation": "Jensen DD, et al. Endothelin-converting enzyme 1 and beta-arrestins exert spatiotemporal control of substance P-induced inflammatory signals. J. Biol. Chem. 2014;289:20283\u201320294. doi: 10.1074/jbc.M114.578179.", "ArticleIdList": ["10.1074/jbc.M114.578179", "PMC4106342", "24898255"]}, {"Citation": "Violin JD, Zhang J, Tsien RY, Newton AC. A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C. J. Cell Biol. 2003;161:899\u2013909. doi: 10.1083/jcb.200302125.", "ArticleIdList": ["10.1083/jcb.200302125", "PMC2172956", "12782683"]}, {"Citation": "Halls ML, Poole DP, Ellisdon AM, Nowell CJ, Canals M. Detection and quantification of intracellular signaling using FRET-based biosensors and high content imaging. Methods Mol. Biol. 2015;1335:131\u2013161. doi: 10.1007/978-1-4939-2914-6_10.", "ArticleIdList": ["10.1007/978-1-4939-2914-6_10", "26260599"]}, {"Citation": "West AP, et al. TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature. 2011;472:476\u2013480. doi: 10.1038/nature09973.", "ArticleIdList": ["10.1038/nature09973", "PMC3460538", "21525932"]}, {"Citation": "Ramirez-Ortiz ZG, et al. The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity. Nat. Immunol. 2015;16:495\u2013504. doi: 10.1038/ni.3143.", "ArticleIdList": ["10.1038/ni.3143", "PMC4406861", "25848864"]}, {"Citation": "Kanno A, et al. Essential role for Toll-like receptor 7 (TLR7)-unique cysteines in an intramolecular disulfide bond, proteolytic cleavage and RNA sensing. Int. Immunol. 2013;25:413\u2013422. doi: 10.1093/intimm/dxt007.", "ArticleIdList": ["10.1093/intimm/dxt007", "23446849"]}, {"Citation": "Rajendran L, et al. Efficient inhibition of the Alzheimer\u2019s disease beta-secretase by membrane targeting. Science. 2008;320:520\u2013523. doi: 10.1126/science.1156609.", "ArticleIdList": ["10.1126/science.1156609", "18436784"]}, {"Citation": "Mishina NM, et al. Does cellular hydrogen peroxide diffuse or act locally? Antioxid. Redox Signal. 2011;14:1\u20137. doi: 10.1089/ars.2010.3539.", "ArticleIdList": ["10.1089/ars.2010.3539", "20690882"]}, {"Citation": "Schappi M, et al. Branched fungal beta-glucan causes hyperinflammation and necrosis in phagocyte NADPH oxidase-deficient mice. J. Pathol. 2008;214:434\u2013444. doi: 10.1002/path.2298.", "ArticleIdList": ["10.1002/path.2298", "18098349"]}, {"Citation": "King PT, et al. Lung T-cell responses to nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. 2013;131:1314\u20131321. doi: 10.1016/j.jaci.2012.09.030.", "ArticleIdList": ["10.1016/j.jaci.2012.09.030", "23142009"]}, {"Citation": "Pollock JD, et al. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 1995;9:202\u2013209. doi: 10.1038/ng0295-202.", "ArticleIdList": ["10.1038/ng0295-202", "7719350"]}, {"Citation": "Judkins CP, et al. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice. Am. J. Physiol. Heart Circ. Physiol. 2010;298:H24\u2013H32. doi: 10.1152/ajpheart.00799.2009.", "ArticleIdList": ["10.1152/ajpheart.00799.2009", "19837950"]}, {"Citation": "Schindelin J, et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods. 2012;9:676\u2013682. doi: 10.1038/nmeth.2019.", "ArticleIdList": ["10.1038/nmeth.2019", "PMC3855844", "22743772"]}]}], "History": [{"Year": "2016", "Month": "11", "Day": "13"}, {"Year": "2017", "Month": "4", "Day": "28"}, {"Year": "2017", "Month": "4", "Day": "12"}, {"Year": "2017", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "11", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["28701733", "PMC5507984", "10.1038/s41467-017-00057-x", "10.1038/s41467-017-00057-x"]}}]}